Form 8-K - Current report:
SEC Accession No. 0001023024-26-000049
Filing Date
2026-05-08
Accepted
2026-05-08 06:56:34
Documents
13
Period of Report
2026-05-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ani-20260508.htm   iXBRL 8-K 27932
2 EX-99.1 anip-20260508xexx991.htm EX-99.1 251490
6 GRAPHIC a1a.jpg GRAPHIC 5505
  Complete submission text file 0001023024-26-000049.txt   424658

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ani-20260508.xsd EX-101.SCH 1755
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ani-20260508_lab.xml EX-101.LAB 21629
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ani-20260508_pre.xml EX-101.PRE 12491
16 EXTRACTED XBRL INSTANCE DOCUMENT ani-20260508_htm.xml XML 2707
Mailing Address 104 CARNEGIE CENTER DRIVE SUITE 300 PRINCETON NJ 08540
Business Address 104 CARNEGIE CENTER DRIVE SUITE 300 PRINCETON NJ 08540 6097591810
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31812 | Film No.: 26955985
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)